How about the Japanese proton heavy ion technology, to go for treatment?

Proton heavy ion** is an "upgrade" to radiotherapy. Protons and heavy ions are both particle rays, which have the characteristics of instantly releasing energy to form the Bragg peak after reaching a certain depth, which can accurately target tumor lesions and blast tumor cells at a fixed point like missiles to avoid damage to normal tissues as much as possible.

Compared with traditional radiotherapy, Japanese proton heavy ion has the advantages of no trauma, small size, protection of adjacent organs, and reduction of the first rate, which can greatly reduce the pain of patients in the process, reduce the secondary rate of almost all indications, and improve the future quality of life of patients, especially for pediatric cancer patients, which has benefited a lot: whether it is in the control of tumors or future survival and quality of life, it has good efficacy.

In Japan, the application of heavy ion radiotherapy equipment in some hospitals has been relatively mature, and the number of cancer patients receiving heavy ion** is also increasing year by year. Many people choose to go to Japan to receive proton heavy ion**, because Japan is one of the countries with the most proton heavy ion** equipment in the world, with 14 proton institutions, 6 heavy ion institutions, and abundant medical resources. Moreover, Japan has rich experience, and as early as 1994, Japan began to apply this technology in clinical practice.

Going abroad for medical treatment or physical examination is a prudent matter, and you must choose a professional and reliable service agency for medical treatment abroad. It can also connect with doctors in Japanese hospitals through Duomu Health, which reduces a lot of unnecessary trouble.

Japan's proton heavy ion medical technology is good, you can try it.

Proton and heavy ion technology is one of the radiotherapy, is internationally recognized as the cutting-edge technology of radiotherapy, proton and heavy ion belong to the same particle line, different from the traditional photon line, the particle ray can form the energy Bragg peak, which can reduce the damage to healthy tissues while carrying out concentrated blasting of tumors.

Expansion: When protons or carbon ions are accelerated to about 70% of the speed of light by synchrotrons, these ion rays are drawn out and emitted into the human body, before reaching the tumor lesion, the radiation energy is not much, but after reaching the lesion, the radiation will instantly release a large amount of energy, forming an energy release trajectory called "Bragg peak", the whole process is like a "stereotactic blasting" for the tumor, which can carry out strong irradiation on the tumor lesion, and at the same time avoid irradiation of normal tissues to maximize the efficacy.

Unforgettable. Life for a lifetime, total.

Although proton heavy ions** bring new hope to cancer patients, proton heavy ions** do not lead to all cancers. The clinical results show that the proton heavy ion technology has a good effect on non-small cell lung cancer, prostate cancer, hepatocellular liver cancer, head and neck tumors, central nervous system tumors and other cancers, and the prognosis is better.

Founded in 2001, Japan's Hyogo Prefectural Particle Radiotherapy Center is dedicated to eradicating cancer, a disease that plagues humanity. There are two types of particle lines** - proton lines ** and heavy ion (carbon ions) wire**, both of which can be implemented in this hospital, and the doctor will choose the most suitable method for the patient. In the 10 years from 2003 to February 2012, the hospital has successfully treated 4,513 cancer patients.

Proton heavy ion radiotherapy, because of its high energy level and strong penetration, belongs to the advanced field of radiation, and its indication range has been greatly broadened compared with ordinary photons

Central nervous system tumors: meningioma, pituitary tumor, acoustic neuroma, astrocytoma, skull base tumor: chordoma, chondrosarcoma.

Head and neck tumors: nasopharyngeal cancer, oral cancer, pharyngeal cancer, laryngeal cancer.

Thoracic and abdominal tumors: lung cancer, esophageal cancer, liver cancer, pancreatic cancer.

Pelvic tumors: prostate cancer, uterine tumors, and other unresectable pelvic tumors, bone tumors, and soft tissue sarcomas.

The Japanese hospitals that we partner with are experts in this area, so you can consult with us if you need it.

But the mouth is just a general statement: big.

About What tumors can proton heavy ions have? How much does an oncology cost? Click on the link below to answer this question!

What tumors can proton heavy ions have? How much does an oncology cost?

1. East Hospital, National Cancer Center, Japan.

The National Cancer Center East Hospital was the first medical institution in Japan to introduce the proton line** system for medical treatment, and it is also the second medical institution in the world to start clinical application. Rich clinical experience in proton lines** ranks among the top in the world.

2. Research Center for Proton Beam Medical Utilization, University of Tsukuba.

In 1983, the University of Tsukuba was the first university in Japan to conduct clinical research on proton lines**, and in September 2001, the Proton Ray Medical Utilization Research Center of our hospital was opened.

Proton Line ** facility at the University Hospital. Including the high-energy accelerator research institute before the opening of the center, the number of cases at our hospital has reached about 3,000. Among them, liver cancer is more common, with nearly 1,000 cases, followed by lung cancer and prostate cancer.

The irradiation method developed by our center is now an international standard for respiratory synchronym radiotherapy**, and the development of this skill has made it possible to perform proton radiotherapy** for liver cancer and lung cancer.

Proton heavy ion is a very good method for cancer, but it is not suitable for everyone, only a suitable method is a good method.

Japan is one of the countries with the largest number of proton heavy ion** devices in the world.

There are 14 proton institutions and 6 heavy ion institutions, and the medical resources are abundant.

Japan's proton and heavy ion equipment has advanced technology and leads the world.

It has the world's only heavy ion 360° rotation frame and breathing gating technology.

There are many cases of proton heavy ion** in Japan, the technology is mature in commercial use, and the doctors are experienced.

By the end of 2016, there were 17,331 heavy ion ** cases in Japan, accounting for 80% of the total number of heavy ion cases in the world

By the end of 2016, the number of proton** cases in Japan was 23,842, and the technology for commercial use was quite mature.

80% of the world's heavy ions** are produced in Japan, including 10,692 cases at the National Institute of Radiological Sciences.

Japan has the lowest cost of proton heavy ion** in the world and is the closest to China.

Due to the abundance and surplus of medical resources, Japan has the lowest cost of proton and heavy ion cancer** in the world, and Japan is only a 2-hour flight distance from China, making it easy for patients to travel.

For patients who are unfortunate enough to suffer from tumors, there is really no good way to do them in China, and they can consider going to Japan to do proton heavy ions. For example, the National Cancer Center East Hospital, the University of Tsukuba Hospital, and the Nagoya Proton Center are all very good choices for proton heavy ion** methods. Generally, when going to Japan for proton**, Japanese hospitals need to do a comprehensive analysis of the patient's disease, analyze whether the patient is suitable for proton**, and judge whether to accept the patient**, if so, the patient can go through the procedures to make an appointment with the hospital for **; If you do not accept it, the hospital will also issue an analysis report to inform you of the reason for not receiving it.

Patients with advanced lung cancer cannot undergo surgery, and the common chemoradiotherapy method is large, proton heavy ion** may be a better choice for patients with advanced lung cancer. Compared with other chemoradiotherapy, proton heavy ion** advanced lung cancer patients can reduce the burden of lung cancer patients, and can allow advanced lung cancer patients to maintain their original lives while undergoing proton heavy ion** in the outpatient setting, improving the quality of life of lung cancer patients.

For patients with advanced lung cancer**, proton heavy ions have a better effect. According to the data of the Proton Radiology Center of Minami-Tohoku Hospital, a well-known hospital in Japan, patients with stage III non-small cell lung cancer have a 2-year local control rate and a 2-year overall survival rate after receiving proton heavy ion**. At the same time, patients receiving proton heavy ions** have fewer complications and can achieve a better prognosis.

Japan is more experienced in this area and more technologically mature. Japan is one of the countries with the largest number of proton heavy ion** devices in the world. Some of these hospitals also cooperate with the platform of Shenyuan Health in China.

Proton heavy ion** is the world's most advanced, accurate, and effective radiotherapy for a variety of tumors. Proton** is also known as "proton line**" and "proton knife", and like the "gamma knife" and "tomo knife" we have heard of, this is not a "knife" in the real sense, but actually a form of radiotherapy.

Proton is a new type of radiation that has been gradually recognized by everyone in recent years. Compared with traditional radiation, proton significantly increases the killing effect on tumor cells and greatly reduces the toxicity of radiation to normal tissues and organs, so it is internationally recognized as the cutting-edge tumor radiation technology. According to the port.

Ann, health. Compared with other emerging radiotherapies such as tomography, gamma knife, and cyberknife, proton has many advantages such as high accuracy, suitable for children and elderly tumors, small tumors, low tumor rates, and extremely high rates.